Co-amilozide
From Wikipedia, the free encyclopedia
|
Co-amilozide
|
|
| Combination of | |
| Amiloride | Potassium-sparing diuretic |
| Hydrochlorothiazide | Thiazide diuretic |
| Identifiers | |
| CAS number | ? |
| ATC code | C03 |
| PubChem | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Co-amilozide (BAN) is a non-proprietary name used to denote a combination of amiloride and hydrochlorothiazide. Co-amilozide is used in the treatment of hypertension and congestive heart failure with the tendency of the thiazide to cause low potassium levels (hypokalaemia) offset by the potassium-sparing effects of amiloride.
[edit] Formulation
Two strengths of co-amilozide is currently available in the UK:
- 2.5 mg amiloride and 25 mg hydrochlorothiazide, BAN of Co-amilozide 2.5/25 (brand name Moduretic 25)
- 5 mg amiloride and 50 mg hydrochlorothiazide, BAN of Co-amilozide 5/50 (brand name Moduretic)
[edit] References
- British National Formulary 54 September 2007
|
||||||||||||||||||||

